Your browser doesn't support javascript.
loading
Scalable synthesis of bryostatin 1 and analogs, adjuvant leads against latent HIV.
Wender, Paul A; Hardman, Clayton T; Ho, Stephen; Jeffreys, Matthew S; Maclaren, Jana K; Quiroz, Ryan V; Ryckbosch, Steven M; Shimizu, Akira J; Sloane, Jack L; Stevens, Matthew C.
Afiliação
  • Wender PA; Department of Chemistry, Stanford University, Stanford, CA 94305, USA. wenderp@stanford.edu.
  • Hardman CT; Department of Chemical and Systems Biology, Stanford University, Stanford, CA 94305, USA.
  • Ho S; Department of Chemistry, Stanford University, Stanford, CA 94305, USA.
  • Jeffreys MS; Department of Chemistry, Stanford University, Stanford, CA 94305, USA.
  • Maclaren JK; Department of Chemistry, Stanford University, Stanford, CA 94305, USA.
  • Quiroz RV; Stanford Nano Shared Facilities, Stanford University, Stanford, CA 94305, USA.
  • Ryckbosch SM; Department of Chemistry, Stanford University, Stanford, CA 94305, USA.
  • Shimizu AJ; Department of Chemistry, Stanford University, Stanford, CA 94305, USA.
  • Sloane JL; Department of Chemistry, Stanford University, Stanford, CA 94305, USA.
  • Stevens MC; Department of Chemistry, Stanford University, Stanford, CA 94305, USA.
Science ; 358(6360): 218-223, 2017 10 13.
Article em En | MEDLINE | ID: mdl-29026042

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Infecções por HIV / Adjuvantes Imunológicos / HIV-1 / Latência Viral / Fármacos Anti-HIV / Briostatinas Idioma: En Ano de publicação: 2017 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Infecções por HIV / Adjuvantes Imunológicos / HIV-1 / Latência Viral / Fármacos Anti-HIV / Briostatinas Idioma: En Ano de publicação: 2017 Tipo de documento: Article